Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C29H32N2O6S.C4H4O4 |
| Molecular Weight | 652.711 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)\C=C\C(O)=O.COC1=CC=C(OCCCN(C)CCOC2=CC3=C(OCO3)C=C2)C(=C1)[C@H]4SC5=CC=CC=C5N(C)C4=O
InChI
InChIKey=DIEJEELGDWGUCV-CNTJLTAHSA-N
InChI=1S/C29H32N2O6S.C4H4O4/c1-30(14-16-34-21-10-12-25-26(18-21)37-19-36-25)13-6-15-35-24-11-9-20(33-3)17-22(24)28-29(32)31(2)23-7-4-5-8-27(23)38-28;5-3(6)1-2-4(7)8/h4-5,7-12,17-18,28H,6,13-16,19H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1+/t28-;/m1./s1
| Molecular Formula | C29H32N2O6S |
| Molecular Weight | 536.639 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
| Molecular Formula | C4H4O4 |
| Molecular Weight | 116.0722 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Semotiadil (also known as sesamodil or SD 3211) is a (+)-(R)-stereoisomer, the corresponding (−)-(S)-stereoisomer is called levosemotiadil. Semotiadil, a benzothiazine derivative was developed as a novel Ca2+ channel blocker with antiplatelet activity. Experiments on rodents have revealed that the drug had an advantage in the treatment of angina with regard to long-lasting action and selectivity for coronary artery and myocardium. In addition, semotiadil improved survival of rats with monocrotaline-induced pulmonary hypertension: comparison with diltiazem. Semotiadil was studied in phase II clinical trials for the treatment of angina pectoris and hypertension in Europe, and in Japan for the treatment of arrhythmias. However, the further development of semotiadil has now been discontinued.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Semotiadil improves survival of rats with monocrotaline-induced pulmonary hypertension: comparison with diltiazem. | 1996-01-11 |
|
| Pharmacological profile of semotiadil fumarate, a novel calcium antagonist, in rat experimental angina model. | 1995-09 |
|
| Effects of semotiadil fumarate (SD-3211) on renal hemodynamics and function in dogs. | 1992-08-06 |
|
| Tissue selectivity of the novel calcium antagonist sesamodil fumarate in isolated smooth muscles and cardiac muscles. | 1990-03 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:03:27 GMT 2025
by
admin
on
Mon Mar 31 19:03:27 GMT 2025
|
| Record UNII |
48E2Q389VX
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
116476-14-3
Created by
admin on Mon Mar 31 19:03:27 GMT 2025 , Edited by admin on Mon Mar 31 19:03:27 GMT 2025
|
PRIMARY | |||
|
6437846
Created by
admin on Mon Mar 31 19:03:27 GMT 2025 , Edited by admin on Mon Mar 31 19:03:27 GMT 2025
|
PRIMARY | |||
|
m9855
Created by
admin on Mon Mar 31 19:03:27 GMT 2025 , Edited by admin on Mon Mar 31 19:03:27 GMT 2025
|
PRIMARY | Merck Index | ||
|
48E2Q389VX
Created by
admin on Mon Mar 31 19:03:27 GMT 2025 , Edited by admin on Mon Mar 31 19:03:27 GMT 2025
|
PRIMARY | |||
|
DTXSID201034884
Created by
admin on Mon Mar 31 19:03:27 GMT 2025 , Edited by admin on Mon Mar 31 19:03:27 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
|
||
|
|
PARENT -> SALT/SOLVATE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|